PFE posts strong Q2 results with earnings up 30% and revenues up 10% year over year, fueled by rising oncology sales and cost ...

Kennedy jnr announced a crackdown on mRNA vaccine technology and research to develop it, following months of pressure from ...

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...

Pharmaceutical major recorded a revenue jump to $14.65 billion, exceeding the market expectations. The company also raised ...

That kind of shot was first used during the Covid-19 pandemic, but the health secretary has been sharply critical of the ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The trade war between China and the US is entering the next round and reaching a new peak. The Middle Kingdom is restricting ...

Pfizer (NYSE:PFE) stock gains as the company surpasses Q2 2025 expectations with $14.7B revenue and raises its full-year ...

This marks Health Secretary Kennedy Jr's latest effort to weave vaccine scepticism into US policy. Read more at ...

Health Secretary Robert F. Kennedy Jr. has canceled nearly $500 million of grants and contracts for developing mRNA vaccines, ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...